217 related articles for article (PubMed ID: 35671403)
1. Maximizing the integration of virtual and experimental screening in hit discovery.
Bajusz D; Keserű GM
Expert Opin Drug Discov; 2022 Jun; 17(6):629-640. PubMed ID: 35671403
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence-enabled virtual screening of ultra-large chemical libraries with deep docking.
Gentile F; Yaacoub JC; Gleave J; Fernandez M; Ton AT; Ban F; Stern A; Cherkasov A
Nat Protoc; 2022 Mar; 17(3):672-697. PubMed ID: 35121854
[TBL] [Abstract][Full Text] [Related]
3. The holistic integration of virtual screening in drug discovery.
Tanrikulu Y; Krüger B; Proschak E
Drug Discov Today; 2013 Apr; 18(7-8):358-64. PubMed ID: 23340112
[TBL] [Abstract][Full Text] [Related]
4. Integrating virtual screening and combinatorial chemistry for accelerated drug discovery.
López-Vallejo F; Caulfield T; Martínez-Mayorga K; Giulianotti MA; Nefzi A; Houghten RA; Medina-Franco JL
Comb Chem High Throughput Screen; 2011 Jul; 14(6):475-87. PubMed ID: 21521151
[TBL] [Abstract][Full Text] [Related]
5. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
6. Advances in machine intelligence-driven virtual screening approaches for big-data.
Kumar N; Acharya V
Med Res Rev; 2024 May; 44(3):939-974. PubMed ID: 38129992
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence in virtual screening: Models versus experiments.
Arul Murugan N; Ruba Priya G; Narahari Sastry G; Markidis S
Drug Discov Today; 2022 Jul; 27(7):1913-1923. PubMed ID: 35597513
[TBL] [Abstract][Full Text] [Related]
8. Future challenges with DNA-encoded chemical libraries in the drug discovery domain.
Zhao G; Huang Y; Zhou Y; Li Y; Li X
Expert Opin Drug Discov; 2019 Aug; 14(8):735-753. PubMed ID: 31111767
[No Abstract] [Full Text] [Related]
9. Recent applications of artificial intelligence in RNA-targeted small molecule drug discovery.
Morishita EC; Nakamura S
Expert Opin Drug Discov; 2024 Apr; 19(4):415-431. PubMed ID: 38321848
[TBL] [Abstract][Full Text] [Related]
10. Discovery of RNA-targeted small molecules through the merging of experimental and computational technologies.
Morishita EC
Expert Opin Drug Discov; 2023 Feb; 18(2):207-226. PubMed ID: 36322542
[TBL] [Abstract][Full Text] [Related]
11. Hierarchical virtual screening approaches in small molecule drug discovery.
Kumar A; Zhang KY
Methods; 2015 Jan; 71():26-37. PubMed ID: 25072167
[TBL] [Abstract][Full Text] [Related]
12. Integration of Lead Discovery Tactics and the Evolution of the Lead Discovery Toolbox.
Leveridge M; Chung CW; Gross JW; Phelps CB; Green D
SLAS Discov; 2018 Oct; 23(9):881-897. PubMed ID: 29874524
[TBL] [Abstract][Full Text] [Related]
13. Fragment-based lead discovery on G-protein-coupled receptors.
Visegrády A; Keserű GM
Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
[TBL] [Abstract][Full Text] [Related]
14. Balancing novelty with confined chemical space in modern drug discovery.
Medina-Franco JL; Martinez-Mayorga K; Meurice N
Expert Opin Drug Discov; 2014 Feb; 9(2):151-65. PubMed ID: 24350718
[TBL] [Abstract][Full Text] [Related]
15. Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery.
Yan XC; Sanders JM; Gao YD; Tudor M; Haidle AM; Klein DJ; Converso A; Lesburg CA; Zang Y; Wood HB
J Chem Inf Model; 2020 Sep; 60(9):4144-4152. PubMed ID: 32309939
[TBL] [Abstract][Full Text] [Related]
16. Selecting Approaches for Hit Identification and Increasing Options by Building the Efficient Discovery of Actionable Chemical Matter from DNA-Encoded Libraries.
Foley TL; Burchett W; Chen Q; Flanagan ME; Kapinos B; Li X; Montgomery JI; Ratnayake AS; Zhu H; Peakman MC
SLAS Discov; 2021 Feb; 26(2):263-280. PubMed ID: 33412987
[TBL] [Abstract][Full Text] [Related]
17. The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs.
Fan F; Toledo Warshaviak D; Hamadeh HK; Dunn RT
PLoS One; 2019; 14(1):e0204378. PubMed ID: 30605479
[TBL] [Abstract][Full Text] [Related]
18. Integration of virtual and high throughput screening in lead discovery settings.
Polgár T; Keseru GM
Comb Chem High Throughput Screen; 2011 Dec; 14(10):889-97. PubMed ID: 21843143
[TBL] [Abstract][Full Text] [Related]
19. How far can virtual screening take us in drug discovery?
Kar S; Roy K
Expert Opin Drug Discov; 2013 Mar; 8(3):245-61. PubMed ID: 23330660
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening methods as tools for drug lead discovery from large chemical libraries.
Ma XH; Zhu F; Liu X; Shi Z; Zhang JX; Yang SY; Wei YQ; Chen YZ
Curr Med Chem; 2012; 19(32):5562-71. PubMed ID: 23016548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
